Search Results

0 results for 'Bristol-Myers Squibb Pharmaceuticals'

You can use to get even better search results
March 11, 2022 | New York Law Journal

2nd Circuit Upholds Dismissal of Securities Suit Targeting Bristol-Myers Squibb Over Failed Trial

The panel upheld a lower court's dismissal of a proposed securities class action, which claimed that Bristol-Myers Squibb made material misstatements or omissions around a clinical trial to determine the drug's efficacy for treating certain kinds of lung cancers.
3 minute read
February 28, 2022 | Corporate Counsel

Ex-Amgen In-House Leader Joins Veracyte as General Counsel

Annie McGuire worked her way up the legal department ladder at Amgen and, later, helped lead a biopharma startup through a $13 billion acquisition.
2 minute read
January 25, 2022 | New York Law Journal

Duty To Warn and the Learned Intermediary Doctrine in New York: Does the Duty Require Instructions About How To Mitigate Risk?

The learned intermediary doctrine and federal preemption law would, in all probability, preclude a failure-to-warn claim based on a failure to provide mitigation instructions.
8 minute read
December 13, 2021 | New Jersey Law Journal

Bristol-Myers Squibb, Celgene Face Antitrust Suit Over Cancer Drugs

This suit was surfaced by Law.com Radar. Read the document here.
1 minute read
November 29, 2021 | Insurance Coverage Law Center

Sambrano v. United Airlines, Inc.

As the coronavirus pandemic continues, courts are grappling with pandemic-related issues such as whether COVID-19 vaccine mandates must provide for religious exemptions. We will survey some recent court rulings.
23 minute read
October 15, 2021 | New Jersey Law Journal

Patent Infringement Suit Against Bristol-Myers, Celgene Targets Multiple Sclerosis Treatment

This suit was surfaced by Law.com Radar. Read the document here.
1 minute read
September 29, 2021 | National Law Journal

A Quiet US Supreme Court Term Ahead for IP—With One Potential Explosion

The court is seeking the solicitor general's views on a case that could reset the court's much-maligned patent eligibility law. Beyond that, a fair use case over Andy Warhol artwork and patent dispute over biologic drugs offer a chance of fireworks.
8 minute read
September 29, 2021 | The Recorder

A Quiet US Supreme Court Term Ahead for IP—With One Potential Explosion

Stanford law professor Mark Lemley said he believes the justices would much prefer not to wade back into patent eligibility. But, he said, American Axle and Manufacturing v. Neapco "has an interesting spin because it will look to the justices like real technology, not the weak patents they have encountered before."
8 minute read
Schweizer v. Canon
Publication Date: 2021-08-23
Practice Area: Civil Appeals | Contractual Disputes | Government
Industry:
Court: U.S. Court of Appeals for the Fifth Circuit
Judge: Circuit Judge Higginson
Attorneys:
For plaintiff:
For defendant:
Case number: 20-20071

Relator, who brought suit on behalf of the government against a company for overcharging for office equipment, failed to show how the lower court erred in dismissing the case.

August 18, 2021 | Connecticut Law Tribune

AG Discloses Connecticut's Share: $1.3M From $75M Multistate Settlement With Bristol-Myers Squibb

Connecticut's Medicaid program will get a seven-figure infusion.
4 minute read

TRENDING STORIES

    Resources

    • Corporate Transparency Act Resource Kit

      Brought to you by Wolters Kluwer

      Download Now

    • Revenue, Profit, Cash: Managing Law Firms for Success

      Brought to you by Juris Ledger

      Download Now

    • Law Firm Operational Considerations for the Corporate Transparency Act

      Brought to you by Wolters Kluwer

      Download Now

    • The Ultimate Guide to Remote Legal Work

      Brought to you by Filevine

      Download Now